CLARUS THERAPEUTICS HLDNGS I's ticker is and the CUSIP is 18271L107. A total of 13 filers reported holding CLARUS THERAPEUTICS HLDNGS I in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bracebridge Capital, LLC | 2,002,495 | $10,673,000 | 0.94% |
| Telemetry Investments, L.L.C. | 45,000 | $240,000 | 0.32% |
| Powell Investment Advisors, LLC | 43,000 | $229,000 | 0.14% |
| Virtu Financial LLC | 17,704 | $94,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 43,345 | $231,000 | 0.01% |
| COWEN AND COMPANY, LLC | 10,000 | $53,000 | 0.00% |
| Verition Fund Management LLC | 30,000 | $160,000 | 0.00% |
| ROYAL BANK OF CANADA | 200 | $1,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 100 | $1,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |